MARKETS WE SERVE IN SOUTH EAST ASIA
A Turnkey Solution To Commercialize Your Healthcare products in the Asia Pacific Region. We assist in Registrations and Business Development in the below mentioned Countries. We understand the legal requirements, cultural differences, geo-political situations in these countries and assist you in targeting the entire region via a Single Trusted Partner. The product portfolio we currently handle include Medical Devices, IVDs, cosmetics, and Neutraceuticals.
Global manufacturers are showing immense interest in South East Asian countries including Philippines, Indonesia, Malaysia, Thailand etc (business friendly approach of the new government). Companies either start the process with market research, registrations and/or distributor search. We at Morulaa have a direct hands-on approach for all these processes. We believe that every project has its own requirements. It is important to have a personal direct contact with these medical device distributors, regulators, KOLs, hospital and other healthcare professionals.
Below is the list of markets for which we provide Regulatory and Distribution Set-up Commercialize-ation services
Markets List the Commercialize-ation Services Provided:
China
India
Indonesia
Japan
Philippines
Vietnam
Thailand
Korea
Malaysia
Taiwan
Hong Kong
Singapore
To show that they are committed to encouraging foreign investments in the medical field, the governments are introducing a series of positive reforms including:
Foreign equity caps in various sectors were relaxed or removed.
Application of licenses made online
Validity of licenses increased to 3 years
Increase in foreign direct investments (FDI)
We have established collaborations with key companies across Asia Pacific and offer Regulatory and Commercialize-ation services across this region. Keep an eye on our blog to learn more about the regulatory and commercialize-ation service and requirements for various countries.
China: Population 1300 M
India: Population 1200 M
Indonesia: Population 246.9 M
Japan: Population 126 M
Philippines: Population 100 M
Vietnam: Population 88 M
Thailand: Population 70 M
Korea: Population 50 M
Malaysia: Population 30 M
Taiwan: Population 23 M
Hongkong: Population 7 M
Singapore: Population 5 M
SPECIALTY HOSPITALS
Due to increasing lifestyle diseases, such as diabetes and coronary heart disease, Asia Pacific is a large marketplace for specialty hospitals.
MEDICAL TOURISM
Driven by rising affluence and increasing demand for quality healthcare, medical tourism is one of the top growth sectors in APAC in the short to medium term
HEALTHCARE IT
To remain competitive by increasing operational efficiency, clinical outcomes and financial profitability, private and public hospitals will invest extensively in installing, maintaining and upgrading IT capabilities.
Testing and Evaluation for Medical Devices/ IVD’s , India
On May 29, 2024, the Central Drugs Standard Control Organisation (CDSCO) issued a crucial circular-
India Drug Barcode New Regulations: Enhancing Safety and Compliance
In a significant move to enhance drug safety and combat counterfeit medicines, the Ministry of
E-Waste Management for Medical Devices in India
E-Waste Management for Medical Devices in India is crucial for maintaining environmental sustainability. On November
CDSCO Compliance: New Order on Self Reporting of Adverse Events
New Delhi, 15 May 2024 – The Central Drugs Standard Control Organisation (CDSCO), under the